about
The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.Effects of repetitive administration of tianeptine, zinc hydroaspartate and electroconvulsive shock on the reactivity of 5-HT(7) receptors in rat hippocampusNitric Oxide Synthase Inhibitor Attenuates the Effects of Repeated Restraint Stress on Synaptic Transmission in the Paraventricular Nucleus of the Rat HypothalamusGroup II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice.5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotoninThe antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodentsImpaired effect of activation of rat hippocampal 5-HT7 receptors, induced by treatment with the 5-HT7 receptor antagonist SB 269970.Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study.Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation.Repeated imipramine administration enhances the effects of NMDA receptor ligands on synchronous activity in rat frontal cortex in vitro.Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.[Use of models for spontaneous paroxysmal activity in studies of adaptive changes in serotonin receptors].Prolonged corticosterone treatment alters the responsiveness of 5-HT1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons.Comparison of the effects of 5-HT1A and 5-HT4 receptor activation on field potentials and epileptiform activity in rat hippocampus.Stress- and antidepressant treatment-induced modifications of 5-HT₇ receptor functions in the rat brain.Glutamate input to noradrenergic neurons plays an essential role in the development of morphine dependence and psychomotor sensitization.Adaptive changes in the reactivity of 5-HT1A and 5-HT2 receptors induced in rat frontal cortex by repeated imipramine and citalopram.Repeated administration of antidepressants decreases field potentials in rat frontal cortex.5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons.The influence of repeated administration of clozapine and haloperidol on the effects of the activation of 5-HT(1A), 5-HT(2) and 5-HT(4) receptors in rat frontal cortex.Repeated restraint stress enhances glutamatergic transmission in the paraventricular nucleus of the rat hypothalamus.Repeated blockade of 5-HT₇ receptors depresses glutamatergic transmission in the rat frontal cortex.Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex.Repeated administration of citalopram and imipramine alters the responsiveness of rat hippocampal circuitry to the activation of 5-HT7 receptors.Imipramine treatment ameliorates corticosterone-induced alterations in the effects of 5-HT1A and 5-HT4 receptor activation in the CA1 area of rat hippocampus.Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region.Prolonged administration of imipramine and (+)-oxaprotiline, but not citalopram, results in sensitization of the rat hippocampal CA1 neurons to serotonin ex vivo.Sensory learning-induced enhancement of inhibitory synaptic transmission in the barrel cortex of the mouse.The role of alpha-1 adrenergic receptors in the stimulating effect of neuropeptide Y (NPY) on rat behavioural activity.Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus.5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area.Repeated treatment with antidepressant drugs induces subsensitivity to the excitatory effect of 5-HT4 receptor activation in the rat hippocampus.Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.Inhibitory effect of intrahippocampal NPY injection on amphetamine-induced behavioural activity.Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022.Erratum to: The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding.Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice
P50
Q24596842-AC885350-8B48-47CD-B8D2-F9222673BAFAQ28566009-9FAE91E8-87F9-4288-A00D-DD8B43A7FE13Q33628613-C24EC3C8-4BA6-4FBA-A7CF-B06514930400Q34138729-F2A61FA5-3BFD-4A75-81BA-5F540D06039AQ35964136-3E0AB20C-B65E-4835-A7E5-7B0EA615E62DQ37122707-EC3810CB-3A07-4E90-9AFE-65475E3D23C8Q41026646-8069943D-54DA-408D-AEB9-A3FC97B74016Q42553107-10916888-BC5E-4EE5-AF34-779770B5594DQ43624533-6448622E-8E75-4796-8F7E-6774F659A10EQ43976984-A29771FA-43EC-4557-906E-569C4425C62EQ44014646-EF6D2B3C-2603-440F-8278-F768B99FC80CQ44113370-D16C7ADD-EF88-46BE-B9A9-E8687A87D254Q44141515-757F7B1E-94D2-487B-9F2F-1282C2651655Q44224145-B3B7E05C-4945-43CD-B3C2-960E04162EA1Q44284822-EEFFF04A-51FF-401E-BE88-E3B4A4DAD7C8Q44394260-8F6566EB-8C29-49AE-8066-AA9D531CB801Q44407262-615572D8-D5EF-448C-B75A-D5E757F18D0DQ44535421-A0107E7D-CBEF-4B25-9658-6D62EF57846AQ44672019-582CDE5E-CD4C-40DF-A26C-038FCA75C77FQ44949111-9530A201-D590-46C8-A595-3ED94C906773Q45105486-E045B82E-05F0-4BAE-95C9-2848EB1A9BA2Q45711238-A0E314CF-AD95-44C4-93EF-D04317A7B513Q46489041-472FC133-E9AD-4343-88F1-38639F40F364Q46651956-9E8A1A7F-E7A8-44AB-ACDF-30D93A75573CQ46777302-ACEA183C-9616-4C48-B9DE-D2FCF7ADF111Q46869894-9DF7839E-5023-4AE8-B511-6C5622BE5CE0Q47821728-9617FB3E-243F-4AB6-BC47-F419D067685FQ48133492-B12EC9F9-46D3-4C38-9C22-069DAE4D0FDEQ48133886-2C74519E-DBF0-4EAE-9F73-E78DE51F5766Q48151967-5EB91BAD-6972-4C2E-81DF-9DF84A16C2CEQ48480492-80FB1D41-0E37-4980-B454-2842207CDBA5Q48484963-46E5B39C-CA91-4755-AE0C-99708442DD28Q48743768-A56EE26D-8044-4709-9D3F-1909B787427EQ48820327-A9DFA1EE-B31E-420A-BDFB-A54BF956C738Q48867540-50D8CFC6-05ED-448E-8AEE-DFFBCA978A3CQ49127106-20EEF620-883C-4330-9E5F-4F9344C0DEB0Q51612347-5A54D7E1-D2BA-4B65-ABA1-7D20E71B80A5Q52147496-0B4BAC9F-F5F9-4274-A79A-CDF47EF21947Q54487582-BEE399ED-2DA0-469D-9AC3-DE9E1838FCECQ60958317-96C3C0CF-3F81-42A9-BAF9-9453A91DFB07
P50
description
Forscher
@de
Polish pharmacologist
@en
Pools farmacoloog
@nl
chercheur
@fr
investigador
@es
polski farmakolog
@pl
ricercatore
@it
研究者
@zh
name
Krzysztof Tokarski
@ast
Krzysztof Tokarski
@ca
Krzysztof Tokarski
@cs
Krzysztof Tokarski
@en
Krzysztof Tokarski
@es
Krzysztof Tokarski
@gl
Krzysztof Tokarski
@hr
Krzysztof Tokarski
@hsb
Krzysztof Tokarski
@it
Krzysztof Tokarski
@nl
type
label
Krzysztof Tokarski
@ast
Krzysztof Tokarski
@ca
Krzysztof Tokarski
@cs
Krzysztof Tokarski
@en
Krzysztof Tokarski
@es
Krzysztof Tokarski
@gl
Krzysztof Tokarski
@hr
Krzysztof Tokarski
@hsb
Krzysztof Tokarski
@it
Krzysztof Tokarski
@nl
prefLabel
Krzysztof Tokarski
@ast
Krzysztof Tokarski
@ca
Krzysztof Tokarski
@cs
Krzysztof Tokarski
@en
Krzysztof Tokarski
@es
Krzysztof Tokarski
@gl
Krzysztof Tokarski
@hr
Krzysztof Tokarski
@hsb
Krzysztof Tokarski
@it
Krzysztof Tokarski
@nl
P106
P1412
P1559
Krzysztof Tokarski
@pl
P21
P214
257144782710113388565
P27
P31
P3124
P496
0000-0002-9157-9024
P734
P735
P7859
viaf-257144782710113388565